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Systemic sclerosis (scleroderIna) is characterized by 
excessive deposition of extracellular Inatrix constitu-
ents . Although it has been proposed that tissue fibro-
sis is due to increased fibroblast synthesis of various 
collagen polypeptides, there is SOIne experiInental 
evidence that patients with systel11ic sclerosis have a 
defect in the control of fibroblast growth. The myb 
family of genes includes, aInong others, the c-myb 
proto-oncogene and the structurally related gene, 
B-myb, which are both iInplicated in the regulation of 
differentiation and/or proliferation of heniatopoietic 
and nonheInatopoietic cells. To elucidate the Inolec-
ular basis responsible for scleroderDl3 fibroblast pro-
liferation, we therefore elected to investigate the 
expression of c-",yb and B-myb genes in scleroderIna 
and control cells. Using the reverse transcriptase 
polyIDerase chain reaction technique, we detected 
c-myb transcripts ill scleroderDla skin fibroblasts ren-
t dered quiescent by serUIn deprivation. Under the 
salDe experiDlental conditions, c-lIIyb Inessage was 
S ystemic sclerosis (scleroderma) is cbaracterized by ex-ten sive fib.rOSiS of the skin and internal organs (Krieg and Meuer , 1988; LeRoy, 1992). Although the initial patho-genic mechanisms are ill defined, fun c tional derange-m en t of afFected organs has been ascribed to obliterative 
microvascular lesions and to excess ive d eposition of extracellular 
matrix (Krieg and M euer, 1988; LeRoy, 1992) . Itl vilro studies have 
demonstrated that scleroderma skin fibroblasts show enhanced 
synthesis of connective tissue proteins (LeRoy, 1972; Uitto el ai, 
1979) associated with elcvated levels of corresponding m essenger 
RNA (Vuorio cl ai, 1985; Jim enez el ai, 1986; Kahari el ai, 1987). 
Furthermore, scle roderma fibroblasts exhibit abnormal cell growth, 
as manifested by persistent proliferation in serum-frce medium and 
by the increased expression of C-III)'C proto-oncogene (Trojanowska 
el ai, 1988) . N everthe less, the molecular m echanism s responsible 
for scleroderma fibroblast prolife rati on remain ihsuffi cicntl y under-
Manuscript received April 4. 1995; revised December 22 . 1995; accepted 
for pu bljcation February 1. 1996. 
Repl; nt requests to: Dr. Armando Gabrielli. Istitu to di Clinica Medica, 
Ospedal e di Touette. 60020 Ancona , Ita ly. 
Abbreviation: EMEM. Eagle's minimulll essential med iulll . 
not found innor111al ski.,. fibroblasts, but, after serUIn 
stiInulation, c-lIIl'b RNA was clearly evident frOIn 3 to 
72 h in both norn'lal and pathologic cells. TreatInent 
of these cells with c-ml'b antisense oligonucleotides 
caused downregulation of c-mJlb expression, and the 
inhibition of scleroderIna fibroblast proliferation was 
42%, whereas in norInal fibroblasts the inhibition was 
weaker (22%). In contrast to c-m)lb, in normal and 
scleroderIna fibroblasts the level of expression of 
B-lIIyb correlated with cell proliferation assessed b y 
cell count, and densitometric analysis showed that 
B-myb l11essage was 1.5-5 tiInes higher in Dlost of 
pathologic cells studied. The antisense B-lIIyl/ oligo-
nucleotides had a weaker antiproliferative effect 
compared with antisense c-myb, inhibiting sclero-
derIna and norInal fibroblasts by 23% and 13%, re-
spectively. These data suggest that the B-mJlb and 
c-lIIyb genes may playa role in scleroderDla fibroblast 
proliferation and function.] Invest Demlatol106:1281-
1286, 1996 
stood, and for this reason we e lected to investigate the possible role 
of othe r gcn cs known to b e in volved in ceU prolifcration . 
T he IIIjI!J family includes the viraU y cncoded v-lIIjlb on cogene, 
w hich is able to induce n eoplastic transformation of hcmatopoietic 
cells influencin g cell growth and difFerenti ation (Moscovici and 
Gazzolo, 1982; R adke e/ ai, 1982). Its normal cellul ar counte rpart. 
the proto-oncogene c-Illyb, codifies for a transcl;ptiOI1 factor of 73 
kDa that seem s to be involved in the regulation of difFcrcntiation 
and/or proliferation of hem atop oictic ceUs (Gewirtz and Cala-
bretta, 1988; Caracciolo ct ai, 1990; Mucensky ct ai, 1991; Valticri 
et ai, 1991) and nonhematopoie tic cell s (Melani cl a/, 1991; 
Raschella el ai, 1992; Simons el ai, 1992; Olson c/ a/, 1993). 
Recently, two lir),b-re lated gcnes, B-III)'!J and A-II/)Ib, have bcen 
cloned (Nomura el a/, 1988), and although the ir function is not yet 
clear, their homology to c-lII),b suggests that they m ay act as 
transcl'iption factors (for review, see Intron a ct at. 1994) . B-III)'b 
protein seem s to play it key rolc in the regulation of hematopoietic 
cell proliferation (Arsura el ai , 1992; Foos cl aI, 1992) and h as been 
found expressed in hem atopoietic cells (Arsura et al. 1992), in 
epithe lial cells (Nomura el ai, 1988), in Balb/c-3T3 cclls. and in 
WI-38 human diploid fibroblasts (Nomura et aI , 1988; Reiss c/ aI, 
1991) . 
Little is available on th e expression of A-III)'b, which has been 
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Tablc I. Dcmographic Fcaturcs of the Systcmic Sclcrosis 
(SSc) Paticnts Includcd in thc Study 
Disease 
Patient Sex/Age DUr:ltion SSc Viscera l 
Number (y) (y) Subset" In vo lvClllc ll t lJ 
M/66 13 dSS c L. E. H 
2 F/56 12 dSS c L, E, GI 
3 F/69 2 dSS c L. E, I-I 
4 F/68 11 dSS c E 
5 F/ 52 13 dSSc L, E 
,/ dSSc. dilfu sc cutaneous SSe. 
/, L. lung; E. esophagus; H. hean; Gr, gnstrointcstina l tra ct. 
observed on ly in a fe w cell lin es of different origins (Nomura cf nl , 
1988) . 
In vie w of these considerations, we tried to assess the potentia l 
role of c- lIl)'b a nd B-III)'b in the pathoge nesis of systenci c sclerosis by 
in vestigatin g their expression in r estin g and prolife ratin g norm a l 
and scleroderma fibrob lasts. 
MATERJALS AND METH ODS 
Cells I-iuman skin fibrob lasts were o braiJled from punch biopsies taken 
from the invo lved skin of the forearm s of five patients w ho fulfill ed the 
prclilninafY c riteria of the Anwrican R.h eulnatisl11 Assoc iation for the 
diagnosis of systemic sclerosi s (Masi e/ III , 1980) . All paticnts had di/f"se 
cutaneous systemic scleros is; their clinical data arc presented in Table I. 
Control fi brob lasts were grown from sk in biopsy specimens offive age- and 
sex-matched healthy subjec ts. Primary explant cul tures were esra blished in 
25_cm2 culture Aasks in Eagle 's minimum essenti," medium (EMEM) 
containing 10% fetal bovine se rum (FllS), 2 mM glu tamine, pen icillin (100 
U / ml). and streptomycin (100 I-tg/ ml) . EM EM with these supplements is 
hcrcaft.c r re ferred to as "culture 111 cdium." Monolayer cultun.:s were 
n1f1intaincd at 37°C in 51yo C O 2 , 
Experimental Fibroblast Cultures Fibroblasts at the fourth subpassage 
were used for all experim ents. BrieAy. fi broblasts we re harvested from 
confluent cultllre~ with tr),psin and plated in culture llI ed ium at the 
concentration reported below. After attachment for 72 h , the cul ture 
medium was di scarded and changed to EMEM containing 0.2% FllS to 
induce cell q uiescence. After a further 48 h of incubation. the medium w"s 
agai n changed to EMEM supplemented with 10'10, FI3S, and cell s were 
co ll ected be fore and at 3, 12, 24, 48 , and 72 h after se rllm stimulation. 
Probes The probe used for detection of the B-/II)'& transcript was an insert 
of2,300 bp, contain.ing the entire coding region of the hu man 13-/II)lb gene, 
o btained afte r restric tion digestion with Ba/llHI of the plasmid pAT-B 18-
13/11)'b . The probe used for detection of the c-lII),b transcript was a fragm e nt 
contailling the fi rst 668 bp of the human C-III )''' eDNA obt"in ed after 
restric tion digestion with EcolU of the plasmid pC M8. The probes were 
labeled with l32 p]dCTP by the random priming standard procedure (Sam-
broo k e/ ai, 1989) to specific activities of 5 X l 0" cpm/ I-tg DNA. 
RNA Isolation and Analysis Tota l cellul"r RN A was extracted accord-
ing to the g uanidine iso thiocyanate-cesium chlo ride m ethod, as described 
elsewhere (Sam brook c/ al. 1989). Fifteen micrograms of total RNA was 
loaded in each lane of a 1 % agarose-formaldeh yde ge l and transferred to 
nylon rn embranes (Dll Pon t. Boston , MA) by standard blotting procedures. 
T he gels as we ll as th e mem bran es were photographed under ultravio let 
light to check for the quan tity and even transfer of RNA. 13I0ts wcre baked 
at 80°C for 2 h . Prehybridiz"tions were performed for 7 h at 60°C in I M 
Na C l, 1 ')I" sod ium dodecy l sulf., te, 10% dextran sulf.1te. and 1 DO I-tg 
denatured sa lmon sperm DNA per rnl. Hybridizatio ns we re performed 
overn ight at 60°C in the same bulle r by "dding 1.2 X la" cpm/ ml of the 
labeled probe. The fi lters we re washed twice fo r 10 min at 60°C with 2 X 
standard sa line citrate/ I % sodium dodec)'1 sul f.1tt!, 15 min with 0.5 X 
standard sa li.ne citrate/ 0.5% sodium dodecyl sul f:lte, and finall y twice at 
room ternper;ltL1I'e with a large vo lume ofO.5 X standa rd saline citrate. The 
blo ts were dri ed and exposed to Kodak X Om" t x-ra)' film w ith two 
inte nsifying screens. Northern blots were quantifi ed by laser densitometric 
scannjng. 
Oligonucleotides The o ligonucleorides used for the experim ents were 
all 18-mer two antisense and two sense o ligonucleotides used as " control. 
The sequence o f each o ligonucleotide was as follows (5' -3' ): B-/II)'b 
antisense. dG C AGCGC GTCCGCCGAGA ; B-III)'b sense, dTCTCGGCG-
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GACGCGCTGC; C-/II)''' antisense, dGTGC GGGGTCTTCGGGC; and 
C-III)''' sense, dGCCCGAAGACCCCGGCAC. T hese o ligonucleotides ha ve 
been shown to inhibit the pro li feration of hematopoietic cells (Introna el nl, 
1994) and of bo ne marrow fibroblasts (Szczylik el ai, 1993). 
Oligomer Treatment of the Cells Fibroblasts were seeded in tripli ca te 
(1 X 103 ce lls/O.l 1111 cul ture medium/ well) in Aat-hottom 96-well plates. 
Afte r attachment, subconAuent fIb rob lasts were washed three tillles with 
phosplwte-buflered sa line and then induced to quiescence in EMEM 
cOlltaining O. 2IYcI F13S for 48 h . Aftc r thi s in cubatioll, the medium was 
changcd to EMEM conta ining 0.2% FBS and the o ligonucleo tides at 30. 60. 
and 1 DO I-tg/ ml. After" 3-h in cuba tion at 37"C. FBS was added to reach 
10'X,. After 24 and 48 h culture, the sa llle o ligonucleotides were added to 
each well to a linal concentration equ iva lent to half of the ini tial dose. The 
fo ll owing da y. the m edium was disca rded and rhe ce ll s were washed twice 
with phosphate-bufl'ered sa line, fi xed with 0.25'10 g lutaraldehyde for 10 min . 
air dri ed. stained with 0.1% crystal vio let fo r 25 mi n , lysed with 0.2% Triton 
X. and counted in a spectro photom eter a t 550 nm. 
Semiquantitative Analysis of RNA by Polymerase Chain Reaction 
(PCR) T otal RNA was "xtracted /iom relativel ), few ce ll s for PCR 
anal ysis by a m odifi ca tion of the m cthod of l3elyavsky e/ al (1989). 
Fibroblasts were lysed in '150 I-tl guanidine thioc),anate so lu tion, and 1 I-tg of 
ycast tllNA . 4.5 I-tl of 2 M sodium acetate, pH 4, 180 I-tl water-saturated 
pheno l, and 35 I-tl chlo rofo rm were added sequentia ll y. T he samples were 
vorrexed. placed o n icc fo r 10 l1Iin . and thcn centrifuged at 12,000g for 10 
111in at 4°C . 
T he warcr phase was co llected. and the RNA was precipitated with 2.7 
vo l ethano l and centrifuged at 12,OOOg for 20 min at 4°C. The pell et was 
washed in 70% ethan ol and resuspended in 3 I-t l of distilled water. T he RN A 
was directl y reverse transcribed in 5 mM MgCI2' 50 mM KCI, 10 mM 
Tris-H C I. pH 8.3,2.5 mM ra ndo m hexam ers. ·1 mM dNTP. I U/ l-tl RNase 
inhibi tor. and 2.5 U / l-tl M-MLV re verse transcriprase. A master mix of a ll 
reagents was prepared on ice, and l 7 I-tl were added to each RNA sa mple . 
The samples were incuba ted for 10 min at room temperature and then for 
45 min at 42°C . Aliquots of the reverse transcription reactions were 
amplifi ed by PC R using sets o f prime rs specifi c fo r C-III)'" or J3-actin in the 
fo ll owing reaction conditions: 2 mM MgCI" 50 111M KC I, 10 111M 
Tris-H C I, 0.2 mM each dNTP. 25 U Ttlq DNA po lym erase pCI' mi. and 5 
ng/m l of each primer. The sequence o f each primer was as fo ll ows: c-lII)'b 
(forward). dCGC GCGCCATGGCCCGAAGACCC: C-/II)''' (reverse), 
dTTCTGGAAGCTTGTGGCCAC TGCTG: J3-acti n (forward) . dCCTTC-
C TGGGC ATGGAGTCCTG; J3-actin (reverse ). dGGAG C AATGATCTT-
GATCTTC. 
PC R was performed in an automated DNA Thermal Cycle r (Perkin-
Elmer, Norwalk. CT) for 22 cycles. The PC R products were run in a 1.5% 
ultrapure agarose gel (J3RL, Bethesda , M D) and transferred to n)'lon 
m embr.)nes by standard Sou thern hlotting procl!dures, T he probes and 
hybridization conditions were identical to those described abo ve for North-
ern blots . 
Statistical Analysis Data arc expressed as lIlean :!: I SO. Mean va lues 
regarding inhibiti on of ce ll prolifera tio ll by o li gonucleotides were compared 
using th e bilateral Mallll-Whitney U tcst. A p value of less th 'lII 0.05 was 
considered to indicate signi fica nce. All va lues arc two-tailed. 
RESULTS 
B-myl1 Gcnc Is Not Exprcsscd in Quicsccnt Fibroblasts and 
Corrclates With Prolifcnltion S"bconAuent monolayers of 
ski n fibroblasts from normal don o rs and sclerode rma patients w e r e 
obtained and made quiescent by inc ubatio n in O.2'X, FBS for 48 h, 
as desc ribed previoLl sly (Troj anowska c/ (I I, 1988) . T he ce ll c Lllcures 
were then stim ulate d by exposure to 1 (J'y., FBS, and cell count and 
B-III)'b express io n w e re eva luated at several interva ls. T h e expe ri-
m ent reported in Fig la is re presentative o f fiv e and shows that the 
sclerode rma and n o rm a l tl brob lasts resp o nde d in a comparable way. 
with a cell count peak after approximate ly 48 h . In agreeme n t with 
prev io u s obse rvatiollS (Reiss et (II, 1991; Lam ct nl , 1992), t h e re was 
a dramatic induc tion ofB-III)'b RNA (Fig Ib,e) that was appare nt 24 
h after FBS addition. 
In a ll the exp e rim ents , t h e peak of the B-III)'u m essage preced ed 
the peak of ac tua l ce ll numbe r , a nd afte r 48 h of stimulation, in 
keeping with t h e findings of Lam ef nl (1992), th e re was a 
d ecreme nt in its level concomi tant with the re du ction il1 ce ll CO Lln t 
(Fig la,II). T he B-III)'b message di sappeared complete ly after 72 h 
in no[ma l fibrob lasts , however. whereas it remaine d re latively high 
for scleroderma fibroblasts (Fig le) . 
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figure 1_ B-",),/, gene expression increases in response to 10'},. FBS 
and correlates with fibroblast proliferation. T he experiment is rcprc-
t sentaove of fiv e. Normal (D . /"",e,. /ill es) and systemic sclerosis ( .... IIppe,. li/les) fibrob lasts were induced to quiescence with 0.2% FBS for 48 h and 
I chell 5 run uJated with 10'X, FBS for 3, 12, 24, 48. and 72 h. After incubation . 
the ceUs ~ere washed, trypsinized, and coullted in a counting chamber. 
Tripllcate wells were used for each experimenta l point. Values arc reported I al mean :!: SD. n, Cell counts throughout the cul ture period; b, densito-
metric anal ysis ofB-I/I )'/' rnRNA detected by Northern blot analysis. c, tota l 
cellul a.r R .NA fi'om patient and normal fibrob lasts, shown in n, was 
extracted and analyzed by Northern blot at the indicated times. Odd and 
even nun.,bers correspond to normal and systemic sclerosis fibroblasts , 
/ respectively. d, photograph of the ethidium bromide-stained 1 ";" forma lde-
hyde agarose gel. 
I I Finally . the feasibility of the comparison be tween normal and 
sderoderTIla B-III)'b expression is w itnessed by the data in Fig 1d, I wh.ich reflect the amount of tota l l~ A per each lane that had been 
i loaded on the gel and transferred to the membran es. When aU the I proliferati ve experiments were an alyzed , the tim e course of one 
normal fibroblast fell above that of the least proliferating sclero-
derma fibrob lasts, and this behavior was reRected by a high er 
expression of B-I/I)'b (data not shown) . 
Expression of the c-IIIyl, Gene Is E levated in Quiescent and 
FBS-StiDlulated Fibroblast s When the blots used to study 
B-/l/yb e:x.jJ ression were repro bed w ith a human c- lIl)'b probe, the 
signal vvas extrem ely weak (data not shown), perhaps reAecting the 
low l evels of c-I/I)'b express io n in these cell s. To study c- I/I)'b 
expressi on, we therefore used a semiquan titative reverse tn1l1-
lCriptase (RT)-PCR approach , deta iled previously (Arsunl el ai , 
Figure 2. c-",yb transcripts increase upon fibroblast stimulation 
with FBS. Normal and scleroderma fib roblasts wcre induced to quiescence 
for 48 h with 0.2% FBS and then stimulated with 10% FBS fo r 3. 12.24.48. 
and 72 h. Total cellular RNA was extracted and c- lII )'b tnll1scripts were 
analyzed by RT-PC R. As control. J3-actin mRNA express ion was ana ly:wd 
in all samples. One experiment representative of fi ve is shown. Odd and 
even numbers correspond to contro l and scleroderma fibrob lasts. respec-
tively . 
1992). Identica l aliquots of tota l RNA were taken fi'om the same 
RNA preparations used to in vestigate B-III)'II transcripts . In all 
cases, the c-lII)'b m essage was clearly augm ented after 12-24 h from 
FBS addition (Fig 2), preceding the highest level in cell count by 
app roximate ly 24 h (Fig 1), and subsequently declined. although it 
maintained at much higher levels in scleroderma fibroblasts (Fig 2), 
as was observed for the B -I/I )'h gene. 
£n add ition , a lt ho ugh no c-I/I)'b message could be observed in the 
quiescent normal fibrob lasts (Fig 3a) , a clear signa l for the c-I/I)'IJ 
gen e was evident in scleroderm a ceUs in similar conditions as shown 
in F ig 3iJ and with th e densitometri c ana lys is in Fig 3c. In aU 
scleroderma fib roblasts studied, C-III)'/J transcripts w ere more highl y 
expressed th an in cells from normal subjec ts. 
Exposure to B-III)l/I and C-III)1iJ Antisense Oligonucleotides 
L owers Fibroblast Proliferation To explore further the fu n c-
tiona l ro le of B-lIIyb and c-I/I)'b expression in scleroderma and 
normal fibrob lasts, w e decided to use the antisense o ligonucleotide 
approach , w hich had been used previously for both gen es (Arsura 
cl ai , 1992; Szczylik c/ nl, 1993). Microcu ltures of fibroblasts were 
first rendered quiescent and subsequen tly stimul ated w ith FBS in 
the presence of antisense o ligonucl eotid es . Although the addition 
of the an tisense o ligonucleotides is never sufficient to arrest the 
proli feration completely, as reported previously (Arsura el nl, 1992; 
Szczyti k cl ai, 1993), never theless , both genes seem to be necessary 
for the full proliferation to occur (Fig 4). 
Inhi bition of scleroderma fibrob last pro liferation by c-lIlyb anti-
sense ol igonucleotides was sta tistically significant at aU doses tes ted 
(p < 0.05; Fig 4a), rang ing from 20'Y., (30 J.Lg/ ml) to 35°;', (60 
f.Lg/ml) and to 42'1., (100 f.Lg / ml) . On the o tller h and, th e addition 
of anti B-III)'b oligon ucleotides did not show a significan t inhibition 
of prollfe ratio n. W hen n01'mal fibrob lasts were tested, significant 
inhibi tio n was presen t after the addi tion of 60 J.Lg/ ml (23 %,) o r 100 
J.Lg / ml (13%) of anti c-lII ),b or of 100 f.Lg / mI (13%) anti .8-III)'b (p < 
0.05; Fig 4 "). In terestingly, at the doses of 60 f.Lg / ml and 100 
J.Lg/m l , the inhibi tory effect by an ti c- lII yb antisense oligonucleo-
tides was more pronounced on scleroderma 'fibro blasts than on 
no rmal fibroblasts (p < 0.05 by Mann- Whitney U test; Fig 4a) . In 
all the experimental condi tions, the addition of the con tro ls (sense 
o ligon ucleotides) did not significalltly affect the cellular response 
(Fig 4). To de te rmine the molecular m ech anism in volved in the 
desc ribed biologic efFect of the antisense o ligo llu cleotides , we 
performed RT-PC R analysis on treated cells. As reported previ-
ously. this ana lys is cou ld be perfo rmed only on the antisense 
c- lII yb-exposed cells, because th e expected m echanism of action of 
the antisense an ti-B-III),b o ligonu cleotides is at the trans la tio nal 
level (Arsura el ai, 1992) . The exposure to anti C-III)'/J antisense 
oligonucleotides w as indeed ab le to dramaticall y reduce the amount 
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Figure 3_ Elevated expression of c-lIIyl, in quiescent scleroderma 
fibroblasts. Fibroblasts from five scleroderma patients and from five 
normal subjects wcre induced to quiescence for 48 h with 0.2'% FBS . Total 
cellular RNA w:,s extracted, and c-lIIyb transcripts wcrc analyzed by 
RT-PCR (a, I,). c, Dcnsitometric analysis of c-lII),b RNA detccted by 
RT-PC R. SSC, systemic scl eroderma. 
of c-lII),b m essage, whcreas no effect was found for the fibroblasts 
exposed to the control o ligonucleotides (Fig 5). 
DISCUSSION 
In this study, the use of RT-PCR allowcd the dctcction of c-IIlyb 
transcripts in scleroderm a fibroblasts whcn their growth had been 
arrested by serum deprivation and the cell s had entered a quiescent 
state. In the samc experimenta l conditions, c-lIIJ'b RNA was n ot 
found in normal skin fibroblasts . 
The re lcvance of thesc findings to pathogenic mechanisms of 
systcmic scle rosis remains un clcar, although after the demonstration 
that the product of c-lII),b is necessary for hem atopoietic (Gewirtz 
and Calabre tta, 1988; Ca racc io lo ct ai, 1990; Mu censky e( ai, 1991; 
Valticri e( ai, 1991) and J1onh cmatopoie tic cell cycle progression 
(Mel"ni e( aI, 1991; R asche lla el ai, 1992; Simon s c( ai, 1992; Olson 
c ( ai, 1993), it is possible that they rcflec t a defec t in the regulation 
of scleroderma fibrobla st fun c tion. In f.Kt, first, c-lII )'b has becn 
de tected in immature cell s, but its exprcssion decreases and disap-
pears as difFerentiation takes place (Westin c( ai, 1982; Craig and 
Bloch, 1984; Gonda and Metcalf, 1984); secon d, constitutive 
overexpression of c-IIIYu pre vents cellular differentiation (Clarke cl 
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Figure 4. c-,lIyl, antisense oligonucleotides lower fIbroblast prolif_ 
eration. Fibroblasts were seeded (1 X 103 ce ll s/O.l 1111 medium) in 
Aat-bottom 96-well platcs. Cells wcrc induced to quiescence with 0.2% FRS 
for 48 h. treated with mediulll cont:lining 10'X. FBS (comrol) or oligonu-
cleotides. il nd thcn counted as reported in iHmerinls allrl i\I1l'lhorls. The resul ts 
arc expressed as percentage of inllibition of growth rcl:,ti vc to control cells 
treated with FBS; va lues arc means ::+:: SD for three different experiments 
with the same fibroblast ce ll lines, each done in triplicate. *p < 0.05 by 
Mann-Whitney U tes t when compared with c-IIIJ'b sense (Fig 4n) and with 
c-IIIJ'b and 13-111)''' sense (Fig 4/,) . • p < 0.05 when compared with normal 
fibroblasts. II. Scleroderma fibroblasts; ". normal fibroblasts. C-III)''' anti sense 
(1!i!I); c-lIIJ'b sense (_): 13-111)'" antisense (~: 13-111)''' sense (0). 
ai, ·'988; M cMahon e( ai, 1988; Selvakumaran e( ai , 1992); and 
fi nally, inhibition of C-IIIYU cxprcssion by antisense c-IIIYu oligonu-
cleotides indu ces growth arrest of severa l hemato poie ti c (Gewirtz 
and Calabretta, 1988; Anfossi e/ ai, 1989; Gewirtz el ai, 1989; 
Valtie ri cl ai, 1991; Arsura cI ai, 1992) and nonh ematopoietic cell 
lines (M elani e( ai, 1991 ; Raschella c( ai, 1992; Simons e( ai , 1992: 
Si m ons and Rosenberg, 1992). 
Furthermore, a pivotal rolc for c-llI)'b in the contro l of differen-
tiation has been postulated beca use of the lack of correlation 
between the prolifcrati ve state and C-II/)'u leve ls in different bone 
m arrow subpopula tions (Kastan e( ai, 1989); on th e bas is of data 
showin g th at c-lIlyl, is rcquired for SCF and granulocyte macro -
phage co lo ny-s timulating facto r synthesis by bone marrow fibro-
blasts (Szczylik c( ai, 1993); by the dissociation be tween B-II/J'u and 
c- Illyb expression during the pro liferation and difl:e rentiation of 
human myeloid cell lines (Arsura el ai, 1994); and, finally , by the 
recent report showing that the loss of carboxyl-tcrminal but not 
amino-tcrminal sequen ces can con vert II/)'b into an ill lIilJ() trans-
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Figure 5. c-",yb antisense oligonucleotides lower c-",yb RNA ill 
treated cells. L tl lle 1. cells treated with 10'1., FBS (untreated ce lls) ; I,,"e 2. 
c-",yb a nti sense trea ted cell s; In lie 3, c-",),b sense treated cells. As control , 
jl-actin n,R.NA expression was analyzed in aU samples . 
forming protein for non hematopoietic m esenchymal cells (Press e/ 
ai, 1994) . No data are available, however, regarding skin fibro-
blas ts, particularly fi 'om patients with disorders characterized by 
abnorn, a l fibroblast fun ction such as scleroderma or other fibroti c 
disorde rs. N evertheless, the findings reported here reinforce the 
op1.lll0n that C-II1Yu is not restricted to hematopoietic cells and 
opera t e s in a broader spcctrum of ce ll types than initially acknowl-I edged (Szczylik ef ai, 1993): . . . . 
The n:lccharlism of fibrosIs 111 systemic sclerosIs IS unknown, but 
recent r e ports suggest that, in addition to enhanced extracell ular 
matrix production and deposition , an abnormality of fibrobl ast 
I growth may contributc to the fibroti c lesions (Trojanowska et ai, 
1
1988) . In this respect, particular emphasis has been placcd upon 
fibroblast insensitivity to the induction of quiescence b y serum 
depriva tion and upon persistence of c-II1}'c expression (Trojal1owska 
l
ei ai, 1988). 
Our d a ta, showing that both normal and sclcroderma fibroblasts 
are sen s itive to the addition of c-",yu antisense oligonucleotides, 
wi th a r e duced proliferative capacity upon stimu lation with FBS, 
imply that the C-II1Y{1 gen e is involved in the prolife ration of these 
cell s. A s stated above, however, its presence in quiescent fibroblasts 
leads to the conclusion that this is not its only fun ction. Quitc 
I surprisingly, scl~roderma ~brobl asts . show an ~ven hi~hcr scnsitiv-icy to the additIOn of anti c-II1Yu oitgonucl eotldes With respect to 
Donnal cells; however, w e can only spcculate on this d ifference. 
Perhaps this can be ascribed to the constant expression of the c-,,,),b 
gene obse rved even in the quiescent state or to a peculiar sensitivity 
of scleroderma fibroblasts to extracellu lar signals. Thc extent of the 
inhibition of prolife ration obtained with single antisense oligonu-
cleotide s may be Ijmited because of the supplem entary influence of I other g e nes . 
T h e expression ofB-IIIyb correlates with cell proliferation in both I normal and pathologic fibroblasts, although its peak slightly pre-
J cede s that of cell count. If B-,,,yb is somehow involved in ccll 
prolife r a tion, it is not surprising that the molecular evcnts anticipate 
cell division. These findings are in agreement, however, with other 
reports that have demonstrated that B-IIIyb is more str ictly bound to 
prolife ration than is c-IIIYu (Golay el aI, 1991 ; Arsura el ai, 1992). 
Neverthe less, our experimcnts showing that B-IIIyu is more ex-
presse d than c-,,,yu im ply that B-,,,yb has a difte rcnt role in skin 
fibroblas t proliferatio n , although it cannot be ruled Ollt that its 
over e xpression is not thc cause, but th e efl:ect o f an abnormal 
proliferative state. Further studies are nced ed to clarify the e ffective 
role of l1I)'b genes in this novel cellular targe t and in systcmic 
scleros is. 
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